Biotech Arena Stock Rises On Study In Crohn’s Disease | Investor’s Business Daily

Arena stock jumped early Tuesday on promising data for its non-opioid treatment for Crohn’s disease pain. Olorinab acts on the cannabinoid receptor type 2.

Source: Biotech Arena Stock Rises On Study In Crohn’s Disease | Investor’s Business Daily

Too much gluten while pregnant linked to increased diabetes risk for baby | Society | The Guardian

Experts warn against switching to a gluten-free diet because that may reduce intake of fibre, iron and B-vitamins

Source: Too much gluten while pregnant linked to increased diabetes risk for baby | Society | The Guardian

BPA exposure in US-approved levels may alter insulin response in non-diabetic adults — ScienceDaily

In a first study of its kind study, researchers have found that a common chemical consumers are exposed to several times a day may be altering insulin release. Results of the study indicate that the Food and Drug Administration-approved ‘safe’ daily exposure amount of BPA may be enough to have implications for the development of Type 2 diabetes and other metabolic diseases.

Source: BPA exposure in US-approved levels may alter insulin response in non-diabetic adults — ScienceDaily